Prosecution Insights
Last updated: April 19, 2026
Application No. 17/865,693

COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE

Non-Final OA §103
Filed
Jul 15, 2022
Examiner
YOON, TAE H
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Idemitsu Kosan Co. Ltd.
OA Round
1 (Non-Final)
66%
Grant Probability
Favorable
1-2
OA Rounds
2y 12m
To Grant
92%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allow Rate
953 granted / 1442 resolved
+1.1% vs TC avg
Strong +25% interview lift
Without
With
+25.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 12m
Avg Prosecution
35 currently pending
Career history
1477
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
47.6%
+7.6% vs TC avg
§102
11.6%
-28.4% vs TC avg
§112
23.1%
-16.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1442 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Applicant’s election of a compound 134-1 comprising N as X1 in the reply filed on December 5, 2025 is acknowledged. Because applicant did not distinctly and specifically point out the supposed errors in the restriction requirement, the election has been treated as an election without traverse (MPEP § 818.01(a)). Applicant states that the claims 1, 4, 6-8 and 12-20 would fall within scope of the compound 134-1. The elected compound 134-1 is found to be allowable and thus the examiner further elects and examines a species comprising a sulfur atom as X1 for formula (10). SPECIFICATION OBJECTION The specification is objected since a subsection, “BRIEF DESCRIPTION OF DRAWING”, is missing from page 222 of the specification. Also, a discussion as to Fig. 1 is missing. DRAWING OBJECTION Drawings submitted on October 13, 2022 are objected since each drawing must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 4, 7-8, 12-15 and 17-20 are rejected under 35 U.S.C. 103 as being unpatentable over KR 20210010407 A (Jan. 27, 2021). The examiner provides a clearer version of KR since KR submitted by applicant is not clear. KR teaches an organic compound having a formula 1 at page 3 and various compounds thereof in claim 4. A second compound in the last raw of page 7 comprises Rx and Ry (i.e., two phenyls) different from the recited for the instant formula (1) comprising the recited formula (10) (i.e., X1 is S, Y1 is C, ring A1 is aromatic hydrocarbon ring having 6 ring carbon atoms, R17 is H and m is 1). Machine translated KR teaches that X is CR11R12 in claim 1 and that R11 and R12 are same or different including a substituted or unsubstituted aryl, a substituted or unsubstituted heteroaryl or bonded to each other to form a ring in claim 3 of page 2. Machine translated KR teaches that a meaning of “forming ring” encompasses alicyclic ring, aromatic ring or heterocyclic ring in [0043]. Thus, it would have been obvious to one skilled in the art before the effective filing date of invention to obtain the instantly recited monocyclic ring obtained by mutually bonded Rx and Ry of claim 1 from the alicyclic ring taught for the CR11R12 as the X of Formula 1 taught by KR. The instant invention further recites that at least one of R1-18 is a group represented by -N(R131)(R132) of claim 1. Machine translated KR teaches that R2 to R5 of formula 1 includes halogen groups, a substituted or unsubstituted silyl group or a substituted or unsubstituted amine group in claim 1 of page 1. The substituted amine group taught by KP would encompass the instant recited substitutions for R131 and R132 such as (cyclo)alkyl group having 1-50 carbon atoms, aryl group having 6-50 ring carbon atoms of claim 1. A simplest substituent for substituted amine group would be two alkyl groups. Machine translated KR teaches compounds further substituted with F or Si(CH3) in a fourth raw of page 10. Thus, it would have been obvious to one skilled in the art before the effective filing date of invention to obtain the instantly recited monocyclic ring obtained by mutually bonded Rx and Ry of claim 1 from the alicyclic ring taught for the CR11R12 as the X of Formula 1 taught by KR with an additional substituent such as –N(CH3) (CH3) since Machine translated KR teaches that R11 and R12 are bonded to each other to form a ring and since Machine translated KR teaches substituted amine group as R2 to R5 and since Machine translated KR teaches compounds further substituted with F or Si(CH3) which is taught and equated with the substituted or unsubstituted amine group in KR absent showing otherwise. See In re Mills, 477 F.2d 649, 176 USPQ 196 (CCPA), In re Lamberti, 545 F.2d 747, 750 (CCPA 1976): Reference must be considered for all that it discloses and must not be limited to preferred embodiments or working examples. MPEP 2123. Regarding claim 4, the second compound in the last raw of page 7 meets the claim 4 since it comprises the recited formula (10) (i.e., X1 is S, Y1 is C, ring A1 is aromatic hydrocarbon ring having 6 ring carbon atoms, R17 is H and m is 1). Regarding claim 7, the second compound in the last raw of page 7 comprising H as R1 to R5, R8 to R15 and CH3 as R16 of the recited formula (10) would meet claim 7. Regarding claim 8, the second compound in the last raw of page 7 comprising the formula (10) with the ring A1 being an aromatic hydrocarbon having 6 carbon atoms, X1 being an oxygen atom and Y1 being a carbon atom of the recited formula (10) would meet claim 8. Regarding claim 12, the above discussed simplest substituent for substituted amine group being two alkyl groups would make claim 12 obvious. Regarding claims 13 and 14, the second compound in the last raw of page 7 comprising X1 being an oxygen atom and all of R171 to R174 being a hydrogen wold meet the recited formula (101). Regarding claim 15, the second compound in the last raw of page 7 comprising X1 being an oxygen atom would meet the recited formula (134). Regarding claims 17-20, claims 7-11 of Machine translated KR would meet the claims 17-20. CLAIM OBJECTION Claims 6 and 16 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim, the elected compound (134-1) and any intervening claims. EXAMINER’S COMMENT The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. CN 106467554 A teaches organic compounds 82 and 83 at page 22 comprising two methyl group substituents, but fails to teach or suggest the instant formula (10). Any inquiry concerning this communication or earlier communications from the examiner should be directed to TAE H YOON whose telephone number is (571)272-1128. The examiner can normally be reached Mon-Fri. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Jones can be reached at (571)270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /TAE H YOON/Primary Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Jul 15, 2022
Application Filed
Feb 17, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12595364
THERMOPLASTIC RESIN COMPOSITION FOR AIR INTAKE HOSE WITH IMPROVED HEAT RESISTANCE AND MOLDED ARTICLE COMPRISING SAME
2y 5m to grant Granted Apr 07, 2026
Patent 12593681
SEMICONDUCTOR DEVICE INCLUDING DIELECTRICS MADE OF POROUS ORGANIC FRAMEWORKS, AND METHOD OF FABRICATING THE SAME
2y 5m to grant Granted Mar 31, 2026
Patent 12588411
ORGANIC ELECTROLUMINESCENCE DEVICE AND FUSED POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE
2y 5m to grant Granted Mar 24, 2026
Patent 12577459
QUANTUM DOT DEVICE AND ELECTRONIC DEVICE INCLUDING THE SAME
2y 5m to grant Granted Mar 17, 2026
Patent 12577428
BINDER POLYMER, OBTAINABLE BY COPOLYMERIZING A MONOMER MIXTURE COMPRISING A VINYL MONOMER AND A BUTENOLIDE MONOMER
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
66%
Grant Probability
92%
With Interview (+25.4%)
2y 12m
Median Time to Grant
Low
PTA Risk
Based on 1442 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month